CHANGCHUN HUAPU BIOTECHNOLOGY has a total of 24 patent applications. Its first patent ever was published in 2003. It filed its patents most often in WIPO (World Intellectual Property Organization), Republic of Korea and Brazil. Its main competitors in its focus markets pharmaceuticals, biotechnology and environmental technology are OMNICYTE LTD, IDERA PHARMACEUTICALS and STEMRON INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 8 | |
#2 | Republic of Korea | 3 | |
#3 | Brazil | 2 | |
#4 | Mexico | 2 | |
#5 | New Zealand | 2 | |
#6 | United States | 2 | |
#7 | South Africa | 2 | |
#8 | Canada | 1 | |
#9 | China | 1 | |
#10 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Environmental technology | |
#4 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Microorganisms | |
#3 | Medical preparations | |
#4 | Climate change adaptation technologies | |
#5 | Sugars |
# | Name | Total Patents |
---|---|---|
#1 | Yu Yong-Li | 12 |
#2 | Bao Mu-Sheng | 12 |
#3 | Wang Li-Ying | 12 |
#4 | Wang Liying | 7 |
#5 | Yu Yongli | 7 |
#6 | Mu-Sheng Bao | 2 |
#7 | Yong-Li Yu | 2 |
#8 | Li-Ying Wang | 2 |
#9 | Yu Yong Li | 2 |
#10 | Bao Musheng | 2 |
Publication | Filing date | Title |
---|---|---|
WO2010015148A1 | Oligodeoxynucleotides with function of immunosuppression | |
JP2010035488A | One kind of oligonucleotide and application thereof | |
WO2007012285A1 | Viral infection resistent single strand deoxynucleosides | |
NZ563583A | Oligonucleotides that induce apoptosis for treating B cell neoplasm | |
WO2006079291A1 | Artificial synthetic single strand deoxynucleotide and vaccine composition thereof and the use | |
WO2006056142A1 | Cpg single-strand deoxynucleotides for use as adjuvant | |
CN1526719A | Deoxyoligonucleotide containing CpG single strand for strengthening immunological effect of Protein vaccine |